Shailaja Uttamsingh

A First-in-Human Phase I Study of the Anticancer Stem Cell Agent Ipafricept (OMP-54F28), a Decoy Receptor for Wnt Ligands, in Patients with Advanced Solid Tumors

Antonio Jimeno, Michael A. Gordon, Rashmi Chugh et al. · Clinical Cancer Research · 2017 · 204 citations

Medicine, Oncology, Pharmacology +17

Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer

Jennifer R. Diamond, Carlos Becerra, Donald Richards et al. · Breast Cancer Research and Treatment · 2020 · 149 citations · Full text

Medicine, Oncology, Pharmacology +16

Synergistic effect between EGF and TGF-β1 in inducing oncogenic properties of intestinal epithelial cells

Shailaja Uttamsingh, Xiuliang Bao, Kevin T. Nguyen et al. · Oncogene · 2007 · 146 citations

Life Sciences, Cancer Biology, Oncology +14

Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer

Efrat Dotan, Dana B. Cardin, Heinz‐Josef Lenz et al. · Clinical Cancer Research · 2020 · 70 citations · Full text

Medicine, Oncology, Pharmacology +17

The Role of Phosphatidylinositol 3-Kinase, Rho Family GTPases, and STAT3 in Ros-induced Cell Transformation

Kevin T. Nguyen, Cong S. Zong, Shailaja Uttamsingh et al. · Journal of Biological Chemistry · 2002 · 52 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14